Photo from wikipedia
The injection of botulinum neurotoxin A (BTA) into the prostate represents a minimally invasive treatment in patients with lower urinary tract symptoms (LUTS) associated to benign prostatic hyperplasia (BPH). We… Click to show full abstract
The injection of botulinum neurotoxin A (BTA) into the prostate represents a minimally invasive treatment in patients with lower urinary tract symptoms (LUTS) associated to benign prostatic hyperplasia (BPH). We evaluated the effectiveness of BTA in treating patients with BPH unresponsive to combined medical therapy (CMT), using urodynamic investigations.
Keywords:
benign prostatic;
medical therapy;
injection;
botulinum;
using urodynamic;
prostatic hyperplasia
Journal Title: Neurourology and Urodynamics
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Neurourology and Urodynamics
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!